22 Pages Posted: 20 Jul 2016
Date Written: July 19, 2016
This PowerPoint presentation summarizes why consumer choice and competition are needed to restructure the FDA regulatory system. We need a new system that allows patients, advised by their doctors, to make informed decisions about the use of not-yet-approved drugs versus FDA-approved drugs. Decisions consistent with their own unique health situations and consistent with their own preferences for risk. Three principles of Free To Choose Medicine are described that provide the foundation for such a system. Support for freedom of choice for patients has been gaining momentum as 31 states have passed Right To Try legislation. This state legislation would allow patients with a terminal illness access to not-yet-FDA-approved drugs. Three future political scenarios are laid out as possible responses to the new political environment created by Right To Try. There may be a near-term opportunity for substantial support of Free To Choose Medicine principles in order to achieve the bipartisan goal of better drugs, sooner, at lower cost.
Keywords: Free To Choose Medicine, Right To Try, FDA reform, competition, consumer choice
JEL Classification: A13, D3, D81, E61, H11, I11, I18, L51
Suggested Citation: Suggested Citation
Madden, Bartley J., Free to Choose Medicine and Right to Try (PowerPoint Presentation) (July 19, 2016). Available at SSRN: https://ssrn.com/abstract=2811866